Search for: "Barr Pharmaceuticals Inc"
Results 41 - 60
of 162
Sort by Relevance
|
Sort by Date
11 Nov 2011, 2:00 am
Cephalon, Inc., Plaintiffs in a putative class action alleging violations of the Sherman Antitrust Act sought to compel discovery of certain communications between Defendant Barr Laboratories, Inc. [read post]
1 Nov 2011, 6:08 am
Inc. have experienced problems. [read post]
28 Oct 2011, 7:38 pm
Petitioners’ reply Amicus brief of International Municipal Lawyers Association Barr Laboratories, Inc. v. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
1 Sep 2011, 6:14 am
The AstraZeneca settlement follows settlements by other defendants to the lawsuit, including Teva Pharmaceuticals, Barr Laboratories, Inc., and Sandoz, Inc. [read post]
27 Aug 2011, 7:55 pm
Barr Labs., Inc., 575 F.3d 1341, 1350 (Fed. [read post]
25 Aug 2011, 8:14 am
Barr Labs., Inc., 575 F.3d 1341, 1350 (Fed. [read post]
25 Aug 2011, 8:14 am
Barr Labs., Inc., 575 F.3d 1341, 1350 (Fed. [read post]
24 Aug 2011, 12:03 pm
Barr Pharmaceuticals settled a similar case last year and Watson/Schein Pharmaceuticals Inc. reportedly anticipates an imminent settlement. [read post]
10 Aug 2011, 4:30 am
Barr Labs. [read post]
4 Aug 2011, 7:40 am
Sys., Inc. v. [read post]
26 Apr 2011, 11:15 pm
Barr Pharmaceutical manufactured Claravis, which contains the same active agent as Accutane (isotretinoin). [read post]
25 Mar 2011, 8:29 pm
Barr Labs., Inc., 251 F.3d 955, 962 (Fed. [read post]
14 Mar 2011, 8:12 pm
PaulkAmicus brief of the Government Accountability ProjectPetitioner's reply Title: Barr v. [read post]
13 Mar 2011, 1:50 pm
Barr Labs., Inc., 575 F.3d 1341 (Fed. [read post]
7 Mar 2011, 12:02 pm
., Inc., v. [read post]
28 Feb 2011, 12:36 pm
Barr Laboratories, Inc. [read post]
31 Jan 2011, 8:10 am
Barr Laboratories, Inc. 93 USPQ 2d 1417 (Fed. [read post]
31 Jan 2011, 8:10 am
Barr Laboratories, Inc. 93 USPQ 2d 1417 (Fed. [read post]
19 Jan 2011, 2:44 pm
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
